Boothe Investment Group, Inc. Abb Vie Inc. Transaction History

Boothe Investment Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $8.77 Million - $10.9 Million	-66,483 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$107.43 - $135.93 $28,576 - $36,157	266 Added 0.4%	66,483 $9 Million
Q3 2021 Oct 06, 2021	BUY	$106.4 - $120.78 $196,733 - $223,322	1,849 Added 2.87%	66,217 $7.22 Million
Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $291,326 - $324,554	2,769 Added 4.5%	64,368 $7.36 Million
Q1 2021 Apr 06, 2021	BUY	$102.3 - $112.62 $2.04 Million - $2.24 Million	19,911 Added 47.76%	61,599 $6.67 Million
Q4 2020 Jan 15, 2021	BUY	$80.49 - $108.67 $168,385 - $227,337	2,092 Added 5.28%	41,688 $4.47 Million
Q3 2020 Nov 03, 2020	BUY	$85.91 - $100.83 $23,625 - $27,728	275 Added 0.7%	39,596 $3.47 Million
Q2 2020 Jul 21, 2020	BUY	$73.37 - $98.18 $2.88 Million - $3.86 Million	39,321 New	39,321 $3.86 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Boothe Investment Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Boothe Investment Group, Inc. with notifications on news.